Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells
- 8 June 2016
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 30 (9) , 1805-1815
Abstract
The acquisition of a complete neoplastic phenotype requires cancer cells to develop escape mechanisms from the host immune system. This phenomenon, commonly referred to as ‘immune evasion’, represents a hallmark of cancers and results from a Darwinian selection of the fittest tumor clones. First reported in solid tumors, cancer immunoescape characterizes several hematological malignancies. The biological bases of cancer immunoescape have recently been disclosed and include: (i) impaired HLA-mediated cancer cell recognition (B2M, CD58, CTIIA, CD80/CD86, CD28 and CTLA-4 mutations); (ii) deranged apoptotic mechanisms (reduced pro-apoptotic signals and/or increased expression of anti-apoptotic molecules); and (iii) changes in the tumor microenvironment involving regulatory T cells and tumor-associated macrophages. These immune escape mechanisms characterize both Hodgkin and non-Hodgkin (B and T cell) lymphomas and represent a promising target for new anti-tumor therapies. In the present review, the principles of cancer immunoescape and their role in human lymphomagenesis are illustrated. Current therapies targeting these pathways and possible applications for lymphoma treatment are also addressed.Keywords
This publication has 168 references indexed in Scilit:
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell LymphomaCancer Cell, 2011
- Making sense of regulatory T cell suppressive functionSeminars in Immunology, 2011
- Cancer-Immune Equilibrium: Questions UnansweredCancer Microenvironment, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin LymphomaCell, 2010
- Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph NodesImmunity, 2010
- Intercellular Adhesion Molecule-1-Dependent Stable Interactions between T Cells and Dendritic Cells Determine CD8+ T Cell MemoryImmunity, 2008
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002